I blogged about Emageon recently. Their third quarter was less than stellar. I continue to believe that the mid sized PACS companies will have a difficult time in todays market. They have very little to differentiate them from the major players other than they are smaller. I reiterate that I do believe that the quants are wrong and the fact that these companies have departed from the mean is a sign of a difficult market for them, not because the stock is undervalued. Anyone else have thoughts on this?
Check out the institutional holdings for Emageon.
Technorati tags: Emageon, radiology, finance, business, PACS
0 Comments.